Who we are
The Biomedicine Discovery Institute AI-Protein Design Program (AIPDP) was co-founded by A/Prof. Gavin Knott and A/Prof. Rhys Grinter. Our team is composed of protein chemists, computer scientists, structural biologists and software implementation specialists, who collaborate to implement and test design-build-test-learn systems that deliver the best design outcomes tailored to each project.
Our team
Our collaborators
- Prof. Dena Lyras & Dr. Melanie Hutton (Monash Biomedicine Discovery Institute)
AI-design proteins to combat antimicrobial resistance - A/Prof. Remy Robert (Monash Biomedicine Discovery Institute)
AI-designed biologics targeting GPCRs - Prof. Ross Bathgate (University of Melbourne)
AI-designed biologics targeting GPCRs - A/Prof. David Thal (Monash Institute of Pharmaceutical Sciences)
AI-designed biologics targeting GPCRs - A/Prof. Simon Corrie (Department of Chemical engineering, Monash University)
AI-designed biologics targeting cell surface receptors - Prof. Fasseli Coulibaly (Monash Biomedicine Discovery Institute)
AI-designed protein-based antivirals - Prof. Max Cryle and Dr. Mathias Hansen (Monash Biomedicine Discovery Institute)
Custom ML-solutions to designing novel biosynthetic enzymes